tm logo
Trademark Search
ALENTIS

View On IC.GC.CA

ALENTIS
APPROVED

on 27 Nov 2024

Last Applicant/ Owned by

Alentis Therapeutics AG

Hegenheimermattweg 167ACH-4123 Allschwil

CH

Serial Number

2180571 filed on 07th Feb 2022

Correspondent Address

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

ALENTIS

Trademark usage description

pharmaceutical products for the treatment of cancer, autoimmune diseases and organ fibrosis, all of the aforementioned products for not ophthalmologic Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of cancer, autoimmune diseases and organ fibrosis, all of the aforementioned products for not ophthalmological use; chemical preparations for medical and veterinary use, namely for the treatment of cancer, autoimmune diseases and organ fibrosis, all of the aforementioned products for not ophthalmological use; biological preparations for medical and therapeutic use, namely for the treatment of cancer, autoimmune diseases and organ fibrosis, all the aforementioned products not for ophthalmological use; biopharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.

Classification kind code

11

Class [042]
Scientific and medical research and development in the fields of fibrosis, autoimmune diseases and cancer; biotechnology research services in the fields of fibrosis, autoimmune diseases and cancer; provision of scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancer diseases; providing scientific advice and information in the pharmaceutical and biomedical field.

Classification kind code

11

Class [044]
Medical analysis services for the diagnosis of cancer; RNA or DNA analysis for cancer prognosis and diagnosis; provision of information in the field of prevention, screening, diagnosis and treatment of cancers; providing pharmaceutical and medication advice and information; medical tests.

Classification kind code

11

Mark Details

Serial Number

2180571

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 17th Aug 2023		Search Recorded
Submitted for opposition 20
on 17th Aug 2023		Examiner's First Report
Submitted for opposition 223
on 17th Aug 2023		Total Provisional Refusal
Submitted for opposition 256
on 21st Feb 2023		Notification of Possible Opposition Sent
Submitted for opposition 236
on 28th Jun 2022		Partial Withdrawal - Madrid Protocol
Submitted for opposition 257
on 21st Apr 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 21st Apr 2022		Formalized
Submitted for opposition 1
on 21st Apr 2022		Created
Submitted for opposition 228
on 07th Feb 2022		International Registration
Submitted for opposition 30
on 07th Feb 2022		Filed